Japanese Pharmacopoeia-compliant room temperature storage medium series
Delivering fresh culture media from our domestic factory! A series of media that can be stored at room temperature.
The "Japanese Pharmacopoeia Compliant Room Temperature Storage Medium Series" is a highly convenient medium that can be stored at room temperature between 2 and 25°C. Included in the lineup are the Soybean Casein Digest Agar "BD BBL SCD Agar RT," as described in the Japanese Pharmacopoeia for viable count testing, and the "BD BBL R2A Agar RT," which is mentioned in the quality control of purified water in the Japanese Pharmacopoeia. The "BD BBL R2A Agar RT" is also recommended as a medium for measuring the viable count of auxotrophic bacteria according to the dialysis fluid purification guidelines and the water quality testing methods. 【Features】 ■ Compliant with the Japanese Pharmacopoeia ■ Can be stored at room temperature (2-25°C), enhancing convenience ■ Shelf life of 6 months ■ Manufactured domestically in-house *For more details, please refer to the catalog or feel free to contact us.
Inquire About This Product
basic information
【Composition (per 1L of purified water)】 <BD BBL SCD Agar Medium RT> ■ Casein pancreatic digest: 15.0g ■ Soybean papain digest: 5.0g ■ Sodium chloride: 5.0g ■ Agar: 15.0g ■ pH 7.3±0.2 <BD BBL R2A Agar Medium RT> ■ Proteose peptone No. 3: 0.5g ■ Casamino acids: 0.5g ■ Yeast extract: 0.5g ■ Sodium pyruvate: 0.3g ■ Glucose: 0.5g ■ Magnesium sulfate heptahydrate: 0.05g ■ Soluble starch: 0.5g ■ Potassium hydrogen phosphate: 0.3g ■ Agar: 15.0g ■ pH=7.2±0.2 *For more details, please refer to the catalog or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the catalog or feel free to contact us.
catalog（3）
Download All Catalogs
![[Technical Data] BD BBL(TM) R2A Agar Medium Performance Verification](https://image.mono.ipros.com/public/catalog/image/01/fdf/764932/IPROS5965353433088157110.jpeg?w=120&h=170)
Company information
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.